IRIS Accounts Production v26.2.0.496 09446681 Board of Directors 1.1.25 31.12.25 31.12.25 false true false false true false 22583 349 132712 165805 5274 142873 150021 22583 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh094466812024-12-31094466812025-12-31094466812025-01-012025-12-31094466812023-12-31094466812024-01-012024-12-31094466812024-12-3109446681ns15:EnglandWales2025-01-012025-12-3109446681ns14:PoundSterling2025-01-012025-12-3109446681ns10:Director12025-01-012025-12-3109446681ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3109446681ns10:SmallEntities2025-01-012025-12-3109446681ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3109446681ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3109446681ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3109446681ns10:FullAccounts2025-01-012025-12-3109446681ns10:Director1412024-12-3109446681ns10:Director1412023-12-3109446681ns10:Director1412025-01-012025-12-3109446681ns10:Director1412024-01-012024-12-3109446681ns10:Director1412025-12-3109446681ns10:Director1412024-12-3109446681ns10:Director22025-01-012025-12-3109446681ns10:RegisteredOffice2025-01-012025-12-3109446681ns5:CurrentFinancialInstruments2025-12-3109446681ns5:CurrentFinancialInstruments2024-12-3109446681ns5:Non-currentFinancialInstruments2025-12-3109446681ns5:Non-currentFinancialInstruments2024-12-3109446681ns5:ShareCapital2025-12-3109446681ns5:ShareCapital2024-12-3109446681ns5:RetainedEarningsAccumulatedLosses2025-12-3109446681ns5:RetainedEarningsAccumulatedLosses2024-12-3109446681ns5:ComputerEquipment2025-01-012025-12-3109446681ns5:ComputerEquipment2024-12-3109446681ns5:ComputerEquipment2025-12-3109446681ns5:ComputerEquipment2024-12-3109446681ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3109446681ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3109446681ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-12-3109446681ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-12-31094466812ns10:Director22024-12-31094466812ns10:Director22023-12-31094466812ns10:Director22025-01-012025-12-31094466812ns10:Director22024-01-012024-12-31094466812ns10:Director22025-12-31094466812ns10:Director22024-12-31
REGISTERED NUMBER: 09446681 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

MACKIE UROLOGY LIMITED

MACKIE UROLOGY LIMITED (REGISTERED NUMBER: 09446681)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MACKIE UROLOGY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







DIRECTORS: S J Mackie
Mrs C M Mackie





REGISTERED OFFICE: 15 West Street
Brighton
East Sussex
BN1 2RL





REGISTERED NUMBER: 09446681 (England and Wales)





ACCOUNTANTS: Galloways Accounting Limited
15 West Street
Brighton
East Sussex
BN1 2RL

MACKIE UROLOGY LIMITED (REGISTERED NUMBER: 09446681)

BALANCE SHEET
31 DECEMBER 2025

2025 2024
Notes £    £   
CURRENT ASSETS
Debtors 5 196,115 26,370
Cash at bank and in hand 18,963 22,491
215,078 48,861
CREDITORS
Amounts falling due within one year 6 143,191 44,542
NET CURRENT ASSETS 71,887 4,319
TOTAL ASSETS LESS CURRENT
LIABILITIES

71,887

4,319

CREDITORS
Amounts falling due after more than one
year

7

-

1,500
NET ASSETS 71,887 2,819

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 71,787 2,719
71,887 2,819

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2026 and were signed on its behalf by:





Mrs C M Mackie - Director


MACKIE UROLOGY LIMITED (REGISTERED NUMBER: 09446681)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025


1. STATUTORY INFORMATION

Mackie Urology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents sales of services and is recognised at the point the customer is entitled to consideration.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% straight line

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 January 2025
and 31 December 2025 912
DEPRECIATION
At 1 January 2025
and 31 December 2025 912
NET BOOK VALUE
At 31 December 2025 -
At 31 December 2024 -

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 42,564 830
Directors' loan accounts 150,021 22,583
Prepayments 3,530 2,957
196,115 26,370

MACKIE UROLOGY LIMITED (REGISTERED NUMBER: 09446681)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 1,499 3,000
Trade creditors - 2,436
Tax 92,420 35,598
Social security and other taxes 2,599 1,492
Accrued expenses 46,673 2,016
143,191 44,542

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Bank loans - 1-2 years - 1,500

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2025 and 31 December 2024:

2025 2024
£    £   
S J Mackie and Mrs C M Mackie
Balance outstanding at start of year 22,583 (349 )
Amounts advanced 132,712 165,805
Amounts repaid (5,274 ) (142,873 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 150,021 22,583

This balance represented the maximum amount outstanding during the year. Interest is charged on any overdrawn amounts at the beneficial loan interest rate.